ClinicalTrials.gg
Drug

Colistinmethanesulfonic acid clinical trials

Also written Colistimethate Sodium.

studies test it
19
open now
4
in phase 3
5
first study started
2009

How each study uses colistinmethanesulfonic acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the colistinmethanesulfonic acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
4 Jun 1970 · COLY-MYCIN M · NDA 050108 (FDA, Drugs@FDA)
European Union
13 Feb 2012 · Colobreathe · EMEA/H/C/001225 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Colistin
5

Brand

Colimycin
1
Coly-Mycin
1
Colomycin
1

Other names

Colistimethate Sodium
9
Colistin Sulfomethate
1
Colistimethate
1
Colistin Sodium Methanesulfonate
1

Studies by the year they started

18 studies that test it; most in 2017 (4); 1 more planned to start later

Studies that test colistinmethanesulfonic acid, by start year
YearStudies
20091
20101
20111
20133
20151
20161
20174
20211
20232
20241
20252

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
2
Phase 3
5
Phase 4
7
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 14

Beni-Suef University (2) · Poitiers University Hospital (2) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (2) · Zambon SpA (1) · Mahidol University (1) · National Cancer Institute, Egypt (1) · Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology (1) · GlaxoSmithKline (1)

Often tested with

Tested in the same studies.

Amikacin (2) · Colistin (2) · Meropenem (1) · Tigecycline (1) · Tobramycin (1) · Fosfomycin (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses colistinmethanesulfonic acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Given beside what is tested · 1 — colistinmethanesulfonic acid is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with colistinmethanesulfonic acid

Codes

What other systems call colistinmethanesulfonic acid · ClinicalTrials.gg INT002298

  • MeSH (NLM) C004691colistinmethanesulfonic acidOne source NLM
  • UNII (FDA) DL2R53P963COLISTIMETHATEConfirmed FDA, NLM
  • RxNorm 2708One source FDA

Also registered as colistimethate sodium (UNII XW0E5YS77G · RxNorm 48305).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.